Diabetes patients with hepatitis C may improve kidney and cardiovascular results with antiviral Rx
(dailyRx News) Patients with the hepatitis C virus (HCV), which primarily affects the liver, face a higher chance of getting diabetes. Antiviral HCV medication, however, may improve diabetes outcomes.
About 3.2 million people in the US have chronic HCV, according the Centers for Disease Control and Prevention. Some studies have shown that HCV may trigger diabetes.
Researchers in Taiwan recently found that individuals who have both HCV and diabetes may reduce incidences of kidney disease, stroke and heart attack if they take antiviral therapy.
Read more from RxWiki HERE.